RNU6-311P

Across TCGA pan-cancer cohorts, RNU6-311P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-311P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-311P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-311P expression acts as an unfavorable survival marker, although some lineages such as STAD and PAAD show a favorable association.

STAD, THYM, and GBM are the cancer types where RNU6-311P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	1.000	0.166	.001	36	view →
THYM	DFS	Tertile	All	0.107	0.884	.001	18	view →
GBM	DFS	Tertile	All	0.122	0.263	.013	18	view →
THCA	OS	Tertile	III,IV	0.171	0.788	.001	18	view →
COAD	DFS	Tertile	III,IV	0.167	0.667	.029	18	view →
SARC	OS	Tertile	All	0.524	0.832	.030	15	view →
PAAD	DFS	Tertile	All	0.816	0.330	.034	12	view →
ESCA	DFS	Tertile	All	0.322	0.528	.018	12	view →
SKCM	OS	Tertile	III,IV	0.125	0.447	.048	6	view →
LIHC	OS	Tertile	All	0.198	0.566	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-311P–STAD (OS)

Open the STAD breakdown →